A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined With Paclitaxel and Pegfilgrastim (Neulasta): A Feasibility Study in Patients With Untreated Stage III and IV Ovarian, Tubal or Primary Peritoneal Cancer.
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2013
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Pegfilgrastim (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 17 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.